We’re relentless ambassadors for the best patient care - from diagnosis to diagnostics. The Commercial team at Foundation Medicine works to promote our proven portfolio of testing services. Foundation Medicine testing analyzes the unique mutations and biomarkers of a patient’s cancer and may provide physicians with possible treatment options by indicating if a targeted therapy, immunotherapy, or a clinical trial is available for the physician to explore.
Those patient stories inspire us every day. They will inspire you as well.
Dymeka Harrison, MBA, Chief Commercial Officer
Dymeka Harrison, MBA, joined Foundation Medicine as Chief Commercial Officer in October 2021. In this role, Ms. Harrison is responsible for the development and execution of the company’s global clinical commercial strategy across all product lines. The clinical commercial team partners throughout the oncology ecosystem to support physicians seeking personalized treatment options for their patients and closely collaborates with third-party payers to ensure appropriate diagnostic utilization.
Title | Department | Requisition Identifier | City | State | Country | Location | Department | Category | Summary | Level |
---|---|---|---|---|---|---|---|---|---|---|
Program Manager, Commercial Data Integrations | Commercial Programs | 101919 | United States | United States | Commercial | About the Job The Program Manager, Commercial Data Integrations works on unique projects in precision oncology, enhancing the way health systems provide patient care. This position collaborates closely with FMI’s technology, commercial and globa... | ||||
Account Executive I – Indianapolis | Sales | 101911 | United States | United States | Commercial | About the Job The Account Executive I (AEI) is a field-based role with direct customer engagement in the Sales team within FMI’s Commercial operation. The position is responsible for selling FMI’s suite of specialty products and services, while ... | ||||
Account Executive I - Long Island, NY | Sales | 101905 | United States | United States | Commercial | About the Job The Account Executive I (AEI) is a field-based role with direct customer engagement in the Sales team within FMI’s Commercial operation. The position is responsible for selling FMI’s suite of specialty products and services, while ... |
Discover the only FDA-approved portfolio of comprehensive genomic profiling tests for all solid tumors. With FDA approvals for tissue and blood-based tests, our portfolio can help guide treatment strategies for advanced cancer patients.
Our comprehensive approach to next-generation sequencing and rigorous commitment to quality has set the industry standard. By partnering with biopharma and clinical stakeholders alike, we’ve developed an extensive genomic database and body of research that have strengthened the services we can offer all of our customers.
Learn more about our products and services for providers and our Biopharma partnerships
We are thrilled to announce the FDA approval of FoundationOne®Liquid CDx, FMI’s comprehensive liquid biopsy test, for all solid tumors. This approval is such an important milestone because we can now offer oncologists multiple FDA-approved, high-quality comprehensive genomic profiling options. From a simple blood draw, FoundationOne Liquid CDx can provide physicians and patients with molecular insights to inform treatment decisions whether that be targeted therapies, clinical trials or immunotherapy.
For more about this approval, click here to read the press release.
This website uses cookies.
We use cookies to personalise content such as job recommendations, and to analyse our traffic. You consent to our cookies if you click "I Accept". If you click on "I Do Not Accept", then we will not use cookies but you may have a deteriorated user experience. You can change your settings by clicking on the Settings link on the top right of the device
Enter your details and we will notify you when new roles that might be a fit are posted!
Thank you